FDA Drug Application (020264) for MEGACE by BRISTOL MYERS SQUIBB

Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB

Application Number020264
Product Number001
FormSUSPENSION;ORAL
Dosage40MG/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMEGACE
Active IngredientMEGESTROL ACETATE



Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.